299 related articles for article (PubMed ID: 29778532)
1. Non-alcoholic fatty liver disease: Insights from sphingolipidomics.
Montefusco DJ; Allegood JC; Spiegel S; Cowart LA
Biochem Biophys Res Commun; 2018 Oct; 504(3):608-616. PubMed ID: 29778532
[TBL] [Abstract][Full Text] [Related]
2. Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover.
Simon J; Ouro A; Ala-Ibanibo L; Presa N; Delgado TC; Martínez-Chantar ML
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861664
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Sphingolipidome in NAFLD.
Montefusco D; Lambert J; Anderson A; Allegood J; Cowart LA
Methods Mol Biol; 2022; 2455():279-303. PubMed ID: 35213002
[TBL] [Abstract][Full Text] [Related]
4. Sphingolipids at the Crossroads of NAFLD and Senescence.
Nikolova-Karakashian M
Adv Cancer Res; 2018; 140():155-190. PubMed ID: 30060808
[TBL] [Abstract][Full Text] [Related]
5. Manifold Roles of Ceramide Metabolism in Non-Alcoholic Fatty Liver Disease and Liver Cancer.
Wang K; Wei Y; Xu R; Li Y; Mao C
Adv Exp Med Biol; 2022; 1372():157-168. PubMed ID: 35503180
[TBL] [Abstract][Full Text] [Related]
6. Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis.
Musso G; Cassader M; Paschetta E; Gambino R
Gastroenterology; 2018 Aug; 155(2):282-302.e8. PubMed ID: 29906416
[TBL] [Abstract][Full Text] [Related]
7. Sphingolipid metabolism in non-alcoholic fatty liver diseases.
Régnier M; Polizzi A; Guillou H; Loiseau N
Biochimie; 2019 Apr; 159():9-22. PubMed ID: 30071259
[TBL] [Abstract][Full Text] [Related]
8. Effects of constant light exposure on sphingolipidomics and progression of NASH in high-fat-fed rats.
Yue F; Xia K; Wei L; Xing L; Wu S; Shi Y; Lam SM; Shui G; Xiang X; Russell R; Zhang D
J Gastroenterol Hepatol; 2020 Nov; 35(11):1978-1989. PubMed ID: 32027419
[TBL] [Abstract][Full Text] [Related]
9. Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease.
Zhu C; Huai Q; Zhang X; Dai H; Li X; Wang H
Int J Biol Sci; 2023; 19(1):311-330. PubMed ID: 36594091
[TBL] [Abstract][Full Text] [Related]
10. Identification of Lipid Species Linked to the Progression of Non-Alcoholic Fatty Liver Disease.
Kawano Y; Nishiumi S; Saito M; Yano Y; Azuma T; Yoshida M
Curr Drug Targets; 2015; 16(12):1293-300. PubMed ID: 25850622
[TBL] [Abstract][Full Text] [Related]
11. Stable Isotope-Labeled Lipidomics to Unravel the Heterogeneous Development Lipotoxicity.
Shih LM; Tang HY; Lynn KS; Huang CY; Ho HY; Cheng ML
Molecules; 2018 Nov; 23(11):. PubMed ID: 30400243
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.
Pierantonelli I; Svegliati-Baroni G
Transplantation; 2019 Jan; 103(1):e1-e13. PubMed ID: 30300287
[TBL] [Abstract][Full Text] [Related]
13. Bile acids and sphingolipids in non-alcoholic fatty liver disease.
Jackson KG; Way GW; Zhou H
Chin Med J (Engl); 2022 May; 135(10):1163-1171. PubMed ID: 35788089
[TBL] [Abstract][Full Text] [Related]
14. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G
Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892
[TBL] [Abstract][Full Text] [Related]
15. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
16. The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update.
Hliwa A; Ramos-Molina B; Laski D; Mika A; Sledzinski T
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34199035
[TBL] [Abstract][Full Text] [Related]
17. Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD.
Mashek DG
Mol Metab; 2021 Aug; 50():101115. PubMed ID: 33186758
[TBL] [Abstract][Full Text] [Related]
18. A lipidomic approach to bisphenol F-induced non-alcoholic fatty liver disease-like changes: altered lipid components in a murine model.
Wang X; Wu L; Tao J; Ye H; Wang J; Gao R; Liu W
Environ Sci Pollut Res Int; 2023 Nov; 30(52):112644-112659. PubMed ID: 37837594
[TBL] [Abstract][Full Text] [Related]
19. Discovering a critical transition state from nonalcoholic hepatosteatosis to nonalcoholic steatohepatitis by lipidomics and dynamical network biomarkers.
Sa R; Zhang W; Ge J; Wei X; Zhou Y; Landzberg DR; Wang Z; Han X; Chen L; Yin H
J Mol Cell Biol; 2016 Jun; 8(3):195-206. PubMed ID: 26993042
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E alleviates non-alcoholic fatty liver disease in phosphatidylethanolamine N-methyltransferase deficient mice.
Presa N; Clugston RD; Lingrell S; Kelly SE; Merrill AH; Jana S; Kassiri Z; Gómez-Muñoz A; Vance DE; Jacobs RL; van der Veen JN
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):14-25. PubMed ID: 30300671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
